featured-Reporter

September 26, 2013

Vaccine Research Program lands major NIH renewal

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.

By VUMC News and Communications
September 26, 2013

Grant broadens graduate, postdoc training programs

Vanderbilt University Medical Center has received a five-year, $1.2 million grant from the National Institutes of Health (NIH) to develop “bold and innovative approaches to broaden graduate and postdoctoral training.”

By Bill Snyder
September 26, 2013

Leadership training effort looks to military, business

When Vanderbilt Bill Wilkerson Center director Roland Eavey, M.D., learned of the institution’s prioritized focus on training the next generation of leaders he went to two organizations he knew that were famous for doing that — the military and business schools.

By Craig Boerner
September 26, 2013

Awards honor leadership, commitment, compassion

The most recent Credo Award and Five Pillar Leader Award winners were announced Sept. 18 at the Clinical Enterprise Leadership Assembly at Langford Auditorium.

By Paul Govern
September 19, 2013

Hyundai award helps drive hope for cancer research

Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.

By Christina Echegaray
September 19, 2013

Study tracks clot removal’s effectiveness at treating stroke

Over the past decade, neurointerventionalists have refined techniques for manually removing blood clots causing stroke. Now they are joining forces for a clinical trial to demonstrate the safety and effectiveness of the techniques.

By VUMC News and Communications
September 19, 2013

Transporter linked to autism risk

Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).
By Bill Snyder
September 17, 2013

Researchers identify novel biomarker for diabetes risk

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.
By Kathy Whitney
September 12, 2013

Embolism not about to change young singer’s tune

As a member of the Tune Town Show Chorus, 20-year-old Kyla Hallums was used to belting out songs and thought it strange when she became short of breath on Sept. 1.
By Kathy Whitney
September 12, 2013

Options to treat childhood C. diff. infection studied

After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections.
By VUMC News and Communications
September 12, 2013

MRI used as new tool in predicting lymphedema risk

A new Vanderbilt study is the first to use magnetic resonance imaging (MRI) to noninvasively measure lymphatic flow.
By VUMC News and Communications
September 12, 2013

Program takes new approach to pain management

Patients with chronic pain who are covered by the Vanderbilt Employee Health Care Plan or workers’ compensation system can now enroll in an innovative rehabilitation program that could dramatically change how chronic pain is treated.
By Jill Clendening
September 5, 2013

Travis family’s Vanderbilt legacy grows

By VUMC News and Communications
1 … 120 121 122 123 124 … 151